Yayınlar & Eserler

Yayın Ağı
Makaleler 12
Tümü (12)
SCI-E, SSCI, AHCI (12)
SCI-E, SSCI, AHCI, ESCI (12)
Scopus (12)
TRDizin (6)

1. From Clinical Trial Efficacy to Real-World Effectiveness and Safety: Two-Year Outcomes of Cladribine in Relapsing—Remitting Multiple Sclerosis

Yaşargün D. Ö., TÜRKOĞLU R.
Journal of Clinical Medicine , cilt.15, sa.13, 2026 (SCI-Expanded, Scopus)

2. Diffusion tensor imaging parameters in the presence of optic neuritis in multiple sclerosis

BAYKARA M., Simay Ersöz A., Gündoğan B., Yazıcıoğlu Can İ., AKTAŞ S., TÜRKOĞLU R.
Neurological Research , 2026 (SCI-Expanded, Scopus)

3. Short and Long-Term Effects of Intravenous Methylprednisolone and Plasma Exchange Combination in NMOSD Attacks

Özkan Yaşargün D., Ersöz A. S., TÜRKOĞLU R., TÜZÜN E.
Noropsikiyatri Arsivi , cilt.62, sa.4, ss.354-359, 2025 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

4. Baseline neurofilament light chain and brain-derived neurotrophic factor levels predict development of aggressive multiple sclerosis

Erol Yildiz R., Akbayir E., Kizilay T., Ersöz A. S., Özkan Yaşargün D., Süer D., et al.
Turkish Journal of Medical Sciences , cilt.55, sa.5, ss.1122-1129, 2025 (SCI-Expanded, Scopus, TRDizin)

5. Altered Cerebrospinal Fluid Neurofilament Light Chain but Not Neurogranin Levels Are Associated with Response to Ocrelizumab Treatment in Relapsing-Remitting Multiple Sclerosis: A Preliminary Study

Klzllay T., Akbayir E., Erol R., Demir A. S., Özkan Yaşargün D., YILMAZ V., et al.
European Neurology , cilt.87, sa.4, ss.203-210, 2024 (SCI-Expanded, Scopus)

6. Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod Treatment

Terzi M., Helvacı E. M., Şen S., BOZ C., Çilingir V., Akçali A., et al.
Noropsikiyatri Arsivi , cilt.60, sa.1, ss.23-27, 2023 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

7. Demyelinating Inflammatory Disorders of the Central Nervous System in the Era of COVID-19: Cases with Mild Infectious Symptoms

Özkan Yaşargün D., TÜRKOĞLU R., TÜZÜN E.
Noropsikiyatri Arsivi , cilt.60, sa.3, ss.191-193, 2023 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

8. Retrospective analysis of effectiveness of fingolimod in real life setting in Turkey (REFINE)

Tuncer A., KÜRTÜNCÜ M., Terzi M., UYGUNOĞLU U., GÖNCÜOĞLU C., Yüceyar A. N., et al.
Turkish Journal of Medical Sciences , cilt.53, sa.1, ss.323-332, 2023 (SCI-Expanded, Scopus, TRDizin)

9. Phosphorylated neurofilament heavy chain (Pnfh) in clinically isolated syndrome and multiple sclerosis Klinik İzole Sendrom ve Multipl Sklerozda Fosforile Nörofilament Ağır Zinciri (pNFH)

TÜZÜN E., ŞANLI E., Akbayir E., TÜRKOĞLU R.
Noropsikiyatri Arsivi , cilt.58, sa.4, ss.255-256, 2021 (SCI-Expanded, Scopus, TRDizin)

10. Nivolumab-induced autoantibody negative limbic encephalitis in a patient with Hodgkin lymphoma

Erol-Yıldız R., Kızılay T., TÜZÜN E., Mısırlı H., TÜRKOĞLU R.
Leukemia and Lymphoma , cilt.61, sa.6, ss.1519-1521, 2020 (SCI-Expanded, Scopus)

11. Impact of fingolimod on CD4+ T cell subset and cytokine profile of relapsing remitting multiple sclerosis patients

KÜRTÜNCÜ M., YILMAZ V., Akçay H. İ., TÜRKOĞLU R., ALTUNRENDE B., ÇINAR S., et al.
Journal of Neuroimmunology , cilt.337, 2019 (SCI-Expanded, Scopus)

12. Neurobrucellosis: Clinical, diagnostic, therapeutic features and outcome. Unusual clinical presentations in an endemic region

CERAN N., TÜRKOĞLU R., Erdem I., İNAN A., ÖZTÜRK ENGİN D., Tireli H., et al.
Brazilian Journal of Infectious Diseases , cilt.15, sa.1, ss.52-59, 2011 (SCI-Expanded, Scopus)
Metrikler

Yayın

12

Yayın (WoS)

12

Yayın (Scopus)

12

H-İndeks (WoS)

4

Atıf (Scopus)

124

H-İndeks (Scopus)

4

Atıf (TrDizin)

2

H-İndeks (TrDizin)

1

Atıf (Diğer Toplam)

2

Proje

1

Fikri Mülkiyet

1

Tez Danışmanlığı

9

Açık Erişim

11
BM Sürdürülebilir Kalkınma Amaçları
SDG 3: AMAÇ 3: SAĞLIKLI BİREYLER